Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective - Image 1

£135.00

Edward Elgar Publishing Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Name: Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective
Brand: Edward Elgar Publishing
Price: 135.0 GBP
Availability: InStock

Economics

This is the most expensive it has ever been. Walk away.

£135 today · previous high £135 · all-time low £102

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 631 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £102 (431 days, 68.3%)

Price range: £102 - £135

Price levels: 3 different prices over 631 days

Description

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators. Contributors: R. Arnold, M.A. Bagley, B. Domeij, J. Drexl, R.C. Dreyfuss, C.R. Fackelmann, T. Imura, R. Iseki, N. Lee, R. Moufang, H. Ullrich

Product Specifications

Brand: Edward Elgar Publishing
Format: Hardcover
ASIN: 0857932454
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 30 July 2013
Listed Since: 24 March 2012

Barcode

No barcode data available

Edward Elgar Publishing Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Patent Protection for Second Medical Uses (Aippi Law)

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Oxford University Press - Balancing Wealth and Health Book

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Springer - Innovation and Marketing in Pharmaceutical Industry

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

World Pharmaceutical Industry

Drugs, Patents and Policy: A Contextual Study of Hong Kong

Routledge Pharmaceutical Industry and Public Policy in India

Routledge Economics and Management in the Biopharmaceutical Industry

Routledge: The Japanese Pharmaceutical Industry Evolution Book

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Pharmaceuticals, Corporate Crime and Public Health